Skip to main content
News Icon

New Speaker and Executive Board Member

Prof. Joachim L. Schultze from the LIMES Institute Bonn resigned in his position as speaker and member of the executive board of the Cluster of Excellence.

We wish him all the best for his future tasks in the field of immunology and we are more then happy that he supports the Cluster of Excellence ImmunoSensation as a member of the steering committe and valuable group leader.

As a succesor for the speaker position Prof. Waldemar Kolanus and as succesor for the executive board member position Prof. Elvira Mass, both from the LIMES Institute in Bonn, will replace Prof. Joachim L. Schultze.

Welcome Prof. Kolanus and Prof. Mass in your new roles in the Cluster of Excellence ImmunoSensation2.

Related news

Prof. Dr. Kaan Boztug

News categories: Honors & Funding

Kaan Boztug awarded Novartis Prize

Prof. Dr. Kaan Boztug from the University Hospital Bonn (UKB) receives the Novartis Prize for Therapy-Relevant Immunological Research 2025. The expert in rare diseases of the immune system and blood formation conducted most of the research work that has now been honored in Vienna. His work was supported by an ERC Starting Grant (ImmunoCore, 2012-2018) and an ERC Consolidator Grant (iDysChart, 2019-2025), among others. The science prize, worth 10,000 € is divided into two parts this time and also goes to Prof. Dr. Evelyn Ullrich.
View entry
Gunther Hartmann and Christina Wuebben

News categories: Focus

An RNA key against viruses

Activating the body's antiviral defense system: A novel RIG-I ligand developed at the Medical Faculty of the University of Bonn and the University Hospital Bonn (UKB) helps the body to recognize and fight off certain viruses at an early stage. This molecular structure has potential for the prevention and treatment of viral infections. Based on the research results, there are now plans to develop and market an antiviral nasal spray to protect against viral respiratory infections.
View entry
members of the Bonn-Cumming Host-Directed Pandemic Therapeutics Program

News categories: Focus

Joining forces against future pandemics

Three days of scientific exchange, workshops, and new impulses: Until July 2, 2025, members of the Bonn-Cumming Host-Directed Pandemic Therapeutics Program are gathered at University Hospital Bonn (UKB) for a symposium to reflect on the current state of their research and discuss further steps. The joint program of the Cumming Global Centre for Pandemic Therapeutics at the University of Melbourne and of the University of Bonn aims to combat future pandemics with novel therapeutics.
View entry

Back to the news overview